查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1494815

2030 年医用膜市场预测：按材料、技术、应用、最终用户和地区进行的全球分析

Medical Membranes Market Forecasts to 2030 - Global Analysis By Material, Technology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据Stratistics MRC预测，2024年全球医用膜市场规模将达40亿美元，预计2030年将达到77亿美元，预测期内复合年增长率为11.2%。

医用膜是用于各种医疗应用的专用材料，特别是在医疗保健环境和生物医学研究中。这些膜是薄的半渗透结构，选择性地允许某些物质通过，同时阻止其他物质通过。它们旨在执行特定功能，例如医疗设备和程序中的过滤、分离和药物传输。医用膜用途广泛，包括治疗肾衰竭的血液透析机、心肺体外迴圈机中的血液氧合、药物和生物液体的过滤以及经皮吸收贴片和植入中的药物控制释放。

慢性病增加

慢性疾病如末期肾功能衰竭(ESRD)会导致肾衰竭，需要血液透析机或腹膜透析等肾臟替代治疗。以膜为基础的透析系统依靠特殊的薄膜来过滤血液中的废物和多余的水。高血压和糖尿病等肾臟疾病的危险因素的流行正在推动对透析膜的需求，进而推动市场成长。

先进透析膜高成本

医疗保健提供者和保险公司可能在承担先进的基于膜的医疗技术的成本方面面临挑战，导致患者的自付费用和健康保险费增加。这给家庭预算带来压力，并可能影响支付医疗费用的能力，特别是对于需要持续治疗的慢性或复杂疾病的患者，从而阻碍市场成长。

对高纯度产品的需求不断增长

对高纯度产品不断增长的需求正在推动膜技术的创新和进步，从而导致选择性、效率和可靠性更高的膜的开发。製造商正在投资研发工作，设计具有客製化特性的薄膜，以满足医疗和製药行业高纯度应用的特定要求，从而推动市场成长。

长时间的进程内验证

广泛的验证要求增加了将新膜产品推向市场相关的开发成本。製造商必须投入资源进行验证研究，获得监管部门的核准，并确保遵守品质标准和法规，这会增加开发成本，降低利润率，并减缓市场进入或抑制可能阻碍扩张努力的研发投资。

COVID-19 的影响

世界正在与新冠肺炎 (COVID-19) 大流行作斗争，而新冠肺炎 (COVID-19) 正在全球传播。医用膜主要应用于医药过滤、输液和无菌过滤、生物人工加工、药物输送和血液透析机等领域，由于国家封锁，这些行业的成长略有下降。在许多国家，由于多个行业，特别是运输和供应链的停摆，经济陷入低迷。由于封锁，发展缓慢，需求受到阻碍。在 COVID-19 大流行期间，供需缺口、原材料采购中断和价格波动预计将阻碍化学工业的成长。

聚丙烯（PP）领域预计将在预测期内成为最大的领域

聚丙烯（PP）预计在预测期内需求最高，因为它以其生物相容性而闻名，并且在与活体组织和液体接触时不太可能引起免疫反应或副作用。这一特性使 PP 成为用于过滤、药物传输和组织工程等应用的医用膜的有吸引力的材料。此外，PP具有优异的机械性能，能够适应医疗产业常用的各种灭菌方法，推动了市场成长。

奈米过滤产业预计在预测期内复合年增长率最高

奈米过滤滤膜的孔径比超过滤滤膜更小，因此可以选择性地去除小分子，同时允许大分子通过。这种选择性过滤能力在需要精确分离分子和颗粒的医疗应用中是有利的，例如透析、药物精製和血浆分馏。

占比最大的地区：

由于人们意识的提高、更好的医疗设施的可用性、创新产品的高采用率以及人口中慢性肾臟病率的增加，预计北美将在预测期内占据最大的市场占有率。例如，根据美国国家糖尿病、消化和肾臟疾病研究所2016年的报告，超过661,000名美国患有肾衰竭问题，其中468,000人正在接受透析。

复合年增长率最高的地区：

由于亚太地区人口众多，易患各种慢性病和感染疾病，预计在预测期内将维持最高的复合年增长率。因此，创新技术的引入有望以更低的成本为患者提供更好的解决方案。由于生产设施的增加以满足最终用户不断增长的需求，亚太地区的医用膜市场正在经历显着的成长。例如，Medtronic)于 2014 年在中国开设了一家新的製造工厂，并计划在中国进行其血液透析机系统产品的大部分製造。

免费客製化服务：

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 研究资讯来源
    • 主要研究资讯来源
    • 二次研究资讯来源
    • 先决条件

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 技术分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • COVID-19 的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球医用膜市场：依材料分类

  • 聚丙烯（PP）
  • 丙烯酸纤维
  • 聚二氟亚乙烯(PVDF)
  • 聚砜(PSU) 和聚醚砜(PESU)
  • 聚四氟乙烯 (PTFE)
  • 聚丙烯腈 (PAN)
  • 氧化铝
  • 氧化锆
  • 其他材料

第六章全球医用膜市场：依技术分类

  • 微过滤
  • 超过滤
  • 奈米过滤
  • 逆渗透
  • 透析
  • 电渗析
  • 气体分离
  • 其他技术

第七章全球医用膜市场：依应用分类

  • 血液透析机
  • 药物输送
  • 静脉注射和血液过滤
  • 生物人工器官
  • 人体组织工程
  • 製药过滤
  • 水过滤
  • 其他用途

第八章全球医用膜市场：依最终用户分类

  • 医院/诊所
  • 製药和生物技术公司
  • 研究实验室
  • 学术机构
  • 家庭保健
  • 其他最终用户

第九章全球医用膜市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第10章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十一章 公司概况

  • 3M Company
  • Abbott
  • Aethlon Medical, Inc.
  • Agilent Technologies, Inc.
  • Amniox Medical
  • Asahi Kasei
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd
  • Hangzhou Cobetter Filtration Equipment
  • Johnson & Johnson Services, Inc
  • Koch Membrane Systems
  • Mann+Hummel
  • Medtronic
  • Merck Group
  • NIPRO
  • Pall Corporation
  • Sartorius AG
  • Siemens
  • Thermo Fisher Scientific Inc.
  • WL Gore & Associates
Product Code: SMRC26330

According to Stratistics MRC, the Global Medical Membranes Market is accounted for $4.0 billion in 2024 and is expected to reach $7.7 billion by 2030 growing at a CAGR of 11.2% during the forecast period. Medical membranes are specialized materials used in various medical applications, particularly in healthcare settings and biomedical research. These membranes are thin, semi-permeable structures that selectively allow the passage of certain substances while blocking others. They are designed to perform specific functions such as filtration, separation, or drug delivery in medical devices and procedures. Medical membranes are utilized in a wide range of applications, including hemodialysis for kidney failure treatment, blood oxygenation in cardiopulmonary bypass machines, filtration of pharmaceuticals and biological fluids, and controlled release of drugs in transdermal patches or implants.

Market Dynamics:

Driver:

Rising prevalence of chronic diseases

Chronic diseases such as end-stage renal disease (ESRD) lead to kidney failure, necessitating renal replacement therapies like hemodialysis or peritoneal dialysis. Membrane-based dialysis systems rely on specialized membranes to filter waste products and excess fluids from the blood. The growing prevalence of conditions like hypertension and diabetes, which are risk factors for kidney disease, drives the demand for dialysis membranes which in turn drive the growth of the market.

Restraint:

High cost of advanced membranes

Healthcare providers and insurers may face challenges in covering the costs of advanced membrane-based medical technologies, leading to higher out-of-pocket expenses for patients or increased healthcare premiums. This can strain household budgets and impact the affordability of medical care, especially for individuals with chronic or complex medical conditions requiring ongoing treatment thus hampering the market growth.

Opportunity:

Growing demand for high-purity products

The growing demand for high-purity products drives innovation and advancement in membrane technology, leading to the development of membranes with improved selectivity, efficiency, and reliability. Manufacturers invest in research and development efforts to engineer membranes with tailored properties to meet the specific requirements of high-purity applications in the medical and pharmaceutical industries propel the market growth.

Threat:

Long in-process validation

Extensive validation requirements add to the development costs associated with bringing new membrane products to market. Manufacturers must allocate resources for conducting validation studies, acquiring regulatory approvals, and ensuring compliance with quality standards and regulations, leading to increased development expenses that may reduce profit margins or deter investment in research and development impeding market entry or expansion efforts.

Covid-19 Impact

The world is battling the contagious COVID-19 pandemic, which has spread across the globe. Medical membrane is primarily used in pharmaceutical filtration, IV Infusion & sterile filtration, bio-artificial processes, drug delivery, and hemodialysis; and as an impact of national lockdown, these sectors were experiencing a slight decline in growth rates. In many countries, the economy has dropped due to the halt of several industries, especially transport and supply chain. Demand for the product has been hindered as there is no development due to the lockdown. The demand-supply gap, disruptions in raw material procurement, and price volatility are expected to hamper the growth of the chemical industry during the COVID-19 pandemic.

The polypropylene (PP) segment is expected to be the largest during the forecast period

The polypropylene (PP) is expected to be the largest during the forecast period as it is known for its biocompatibility, meaning it is unlikely to cause an immune response or adverse reactions when in contact with biological tissues or fluids. This property makes PP an attractive material for medical membranes used in applications such as filtration, drug delivery, and tissue engineering. Moreover it has excellent mechanical properties and ability to compatible with various sterilization methods commonly used in the medical industry drive the growth of the market

The nanofiltration segment is expected to have the highest CAGR during the forecast period

The nanofiltration segment is expected to have the highest CAGR during the forecast period as nanofiltration membranes have smaller pore sizes compared to ultrafiltration membranes, allowing them to selectively remove smaller molecules while allowing the passage of larger ones. This selective filtration capability is advantageous in medical applications where precise separation of molecules or particles is required, such as in dialysis, pharmaceutical purification, and blood plasma fractionation.

Region with largest share:

North America is projected to hold the largest market share during the forecast period owing to increasing awareness among the people, availability of better medical facilities, high adoption of the innovative products and increasing prevalence of chronic kidney disorder among the population. For instance, according to the National Institute of Diabetes and Digestive and Kidney Disease 2016 report, more than 661,000 Americans were suffering from kidney failure problems and out of these 468,000 individuals were on dialysis.

Region with highest CAGR:

Asia Pacific is projected to hold the highest CAGR over the forecast period owing to presence of large population prone to various chronic and infectious diseases. Therefore, introduction of innovative techniques are expected to provide better solutions to the patient at the low costs. Medical membrane market is growing at significant rate in the Asia Pacific region, owing to increasing manufacturing facilities to meet increasing demand from end users. For instance, Medtronic opened its new manufacturing facility in China in 2014, in which the company will be focusing most of its hemodialysis system products manufacturing.

Key players in the market

Some of the key players in Medical Membranes market include 3M Company, Abbott, Aethlon Medical, Inc., Agilent Technologies, Inc., Amniox Medical, Asahi Kasei, Danaher Corporation, F. Hoffmann-La Roche Ltd, Hangzhou Cobetter Filtration Equipment, Johnson & Johnson Services, Inc, Koch Membrane Systems, Mann+Hummel, Medtronic, Merck Group, NIPRO, Pall Corporation, Sartorius AG, Siemens, Thermo Fisher Scientific Inc. and W. L. Gore & Associates

Key Developments:

In May 2024, 3M expands facility in Valley, Nebraska. The expansion of the plant is expected to create about 40 new jobs. The $67 million investment includes new production lines, equipment and a warehouse, and will help 3M more quickly meet customer demand for the company's personal safety products.

In March 2024, Abbott, Real Madrid and the Real Madrid Foundation announced the extension of their partnership through Real Madrid's 2026-27 season. Abbott will remain Global Health Sciences and Nutrition Partner of Real Madrid Football Club and Global Partner of the Real Madrid Foundation.

In February 2024, Aethlon Medical Enters Into Materials Transfer Agreement for Santersus AG's NucleoCapture and HemoNucleoCapture Devices. Aethlon Medical Will Perform Pre-Clinical Studies to Explore Potential Synergies With its First-in-Class Hemopurifier(R) Blood Filtration System

Materials Covered:

  • Polypropylene (PP)
  • Acrylics
  • Polyvinylidene Fluoride (PVDF)
  • Polysulfone (PSU) & Polyether Sulfone (PESU)
  • Polytetrafluoroethylene (PTFE)
  • Polyacrylonitrile (PAN)
  • Alumina
  • Zirconia
  • Other Materials

Technologies Covered:

  • Microfiltration
  • Ultrafiltration
  • Nanofiltration
  • Reverse Osmosis
  • Dialysis
  • Electrodialysis
  • Gas Separation
  • Other Technologies

Applications Covered:

  • Hemodialysis
  • Drug Delivery
  • IV Infusion & Blood Filtration
  • Bioartificial Organs
  • Tissue Engineering
  • Pharmaceutical Filtration
  • Water Purification
  • Other Applications

End Users Covered:

  • Hospitals & Clinics
  • Pharmaceutical & Biotechnology Companies
  • Research Laboratories
  • Academic Institutions
  • Home Healthcare
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Technology Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Medical Membranes Market, By Material

  • 5.1 Introduction
  • 5.2 Polypropylene (PP)
  • 5.3 Acrylics
  • 5.4 Polyvinylidene Fluoride (PVDF)
  • 5.5 Polysulfone (PSU) & Polyether Sulfone (PESU)
  • 5.6 Polytetrafluoroethylene (PTFE)
  • 5.7 Polyacrylonitrile (PAN)
  • 5.8 Alumina
  • 5.9 Zirconia
  • 5.10 Other Materials

6 Global Medical Membranes Market, By Technology

  • 6.1 Introduction
  • 6.2 Microfiltration
  • 6.3 Ultrafiltration
  • 6.4 Nanofiltration
  • 6.5 Reverse Osmosis
  • 6.6 Dialysis
  • 6.7 Electrodialysis
  • 6.8 Gas Separation
  • 6.9 Other Technologies

7 Global Medical Membranes Market, By Application

  • 7.1 Introduction
  • 7.2 Hemodialysis
  • 7.3 Drug Delivery
  • 7.4 IV Infusion & Blood Filtration
  • 7.5 Bioartificial Organs
  • 7.6 Tissue Engineering
  • 7.7 Pharmaceutical Filtration
  • 7.8 Water Purification
  • 7.9 Other Applications

8 Global Medical Membranes Market, By End User

  • 8.1 Introduction
  • 8.2 Hospitals & Clinics
  • 8.3 Pharmaceutical & Biotechnology Companies
  • 8.4 Research Laboratories
  • 8.5 Academic Institutions
  • 8.6 Home Healthcare
  • 8.7 Other End Users

9 Global Medical Membranes Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 3M Company
  • 11.2 Abbott
  • 11.3 Aethlon Medical, Inc.
  • 11.4 Agilent Technologies, Inc.
  • 11.5 Amniox Medical
  • 11.6 Asahi Kasei
  • 11.7 Danaher Corporation
  • 11.8 F. Hoffmann-La Roche Ltd
  • 11.9 Hangzhou Cobetter Filtration Equipment
  • 11.10 Johnson & Johnson Services, Inc
  • 11.11 Koch Membrane Systems
  • 11.12 Mann+Hummel
  • 11.13 Medtronic
  • 11.14 Merck Group
  • 11.15 NIPRO
  • 11.16 Pall Corporation
  • 11.17 Sartorius AG
  • 11.18 Siemens
  • 11.19 Thermo Fisher Scientific Inc.
  • 11.20 W. L. Gore & Associates

List of Tables

  • Table 1 Global Medical Membranes Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Medical Membranes Market Outlook, By Material (2022-2030) ($MN)
  • Table 3 Global Medical Membranes Market Outlook, By Polypropylene (PP) (2022-2030) ($MN)
  • Table 4 Global Medical Membranes Market Outlook, By Acrylics (2022-2030) ($MN)
  • Table 5 Global Medical Membranes Market Outlook, By Polyvinylidene Fluoride (PVDF) (2022-2030) ($MN)
  • Table 6 Global Medical Membranes Market Outlook, By Polysulfone (PSU) & Polyether Sulfone (PESU) (2022-2030) ($MN)
  • Table 7 Global Medical Membranes Market Outlook, By Polytetrafluoroethylene (PTFE) (2022-2030) ($MN)
  • Table 8 Global Medical Membranes Market Outlook, By Polyacrylonitrile (PAN) (2022-2030) ($MN)
  • Table 9 Global Medical Membranes Market Outlook, By Alumina (2022-2030) ($MN)
  • Table 10 Global Medical Membranes Market Outlook, By Zirconia (2022-2030) ($MN)
  • Table 11 Global Medical Membranes Market Outlook, By Other Materials (2022-2030) ($MN)
  • Table 12 Global Medical Membranes Market Outlook, By Technology (2022-2030) ($MN)
  • Table 13 Global Medical Membranes Market Outlook, By Microfiltration (2022-2030) ($MN)
  • Table 14 Global Medical Membranes Market Outlook, By Ultrafiltration (2022-2030) ($MN)
  • Table 15 Global Medical Membranes Market Outlook, By Nanofiltration (2022-2030) ($MN)
  • Table 16 Global Medical Membranes Market Outlook, By Reverse Osmosis (2022-2030) ($MN)
  • Table 17 Global Medical Membranes Market Outlook, By Dialysis (2022-2030) ($MN)
  • Table 18 Global Medical Membranes Market Outlook, By Electrodialysis (2022-2030) ($MN)
  • Table 19 Global Medical Membranes Market Outlook, By Gas Separation (2022-2030) ($MN)
  • Table 20 Global Medical Membranes Market Outlook, By Other Technologies (2022-2030) ($MN)
  • Table 21 Global Medical Membranes Market Outlook, By Application (2022-2030) ($MN)
  • Table 22 Global Medical Membranes Market Outlook, By Hemodialysis (2022-2030) ($MN)
  • Table 23 Global Medical Membranes Market Outlook, By Drug Delivery (2022-2030) ($MN)
  • Table 24 Global Medical Membranes Market Outlook, By IV Infusion & Blood Filtration (2022-2030) ($MN)
  • Table 25 Global Medical Membranes Market Outlook, By Bioartificial Organs (2022-2030) ($MN)
  • Table 26 Global Medical Membranes Market Outlook, By Tissue Engineering (2022-2030) ($MN)
  • Table 27 Global Medical Membranes Market Outlook, By Pharmaceutical Filtration (2022-2030) ($MN)
  • Table 28 Global Medical Membranes Market Outlook, By Water Purification (2022-2030) ($MN)
  • Table 29 Global Medical Membranes Market Outlook, By Other Applications (2022-2030) ($MN)
  • Table 30 Global Medical Membranes Market Outlook, By End User (2022-2030) ($MN)
  • Table 31 Global Medical Membranes Market Outlook, By Hospitals & Clinics (2022-2030) ($MN)
  • Table 32 Global Medical Membranes Market Outlook, By Pharmaceutical & Biotechnology Companies (2022-2030) ($MN)
  • Table 33 Global Medical Membranes Market Outlook, By Research Laboratories (2022-2030) ($MN)
  • Table 34 Global Medical Membranes Market Outlook, By Academic Institutions (2022-2030) ($MN)
  • Table 35 Global Medical Membranes Market Outlook, By Home Healthcare (2022-2030) ($MN)
  • Table 36 Global Medical Membranes Market Outlook, By Other End Users (2022-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.